VYOME HOLDINGS, INC. Total Contract Liability
VYOME HOLDINGS, INC. (HIND) had Total Contract Liability of $854.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2025-08-14
- 2025-06-30: Contract with Customer, Liability $854.00K.
- 2025-03-31: Contract with Customer, Liability $838.00K.
- 2024-12-31: Contract with Customer, Liability $720.00K.
- 2024-09-30: Contract with Customer, Liability $683.00K.
| Period end | Contract with Customer, Liability |
|---|---|
| 2025-06-30 | $854.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $838.00K 10-Q · filed 2025-05-20 |
| 2024-12-31 | $720.00K 10-Q · filed 2025-08-14 |
| 2024-09-30 | $683.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $723.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $643.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $639.00K 10-K · filed 2025-04-04 |
| 2023-09-30 | $657.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $459.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $573.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $510.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $644.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $605.00K 10-Q · filed 2022-08-19 |
| 2021-12-31 | $549.00K 10-K · filed 2023-04-17 |
| 2021-09-30 | $580.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $518.00K 10-Q · filed 2021-08-16 |
| 2020-12-31 | $398.00K 10-K · filed 2022-04-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |